Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor	Recruiting	Phase 1 / Phase 2	2026-04-09		NCT05048901

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Changhua Christian Hospital	11
China Medical University Hospital	112
Kaohsiung Medical University Chung-Ho Memorial Hospital	56
Mackay Memorial Hospital	44
National Cheng-Kung University Hospital	83
National Health Research Institutes, Taiwan	52
National Taiwan University Hospital	540
Taichung Veterans General Hospital	63
Taipei Veterans General Hospital, Taiwan	80
Tri-Service General Hospital (TSGH)	36

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chang Gung Medical Foundation	Taoyuan	Taiwan	2
Chang Gung Medical Foundation	Kaohsiung City	Taiwan	3
Changhua Christian Hospital	Changhua	Taiwan	5
China Medical University Hospital	Taichung	Taiwan	54
Kaohsiung Medical University Chung-Ho Memorial Hospital	Kaohsiung City	Taiwan	48
MacKay Memorial Hospital	Taipei	Taiwan	23
National Cheng Kung University Hospita	Tainan	Taiwan	1
National Taiwan University Hospital	Taipei	Taiwan	203
Taichung Veterans General Hospital	Taichung	Taiwan	46
Taipei Veterans General Hospital	Taipei	Taiwan	64
Tri-Service General Hospital	Taipei	Taiwan	27